Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 126 record(s)

Req # A-2019-01539

CMP2019-1255510 Recommendation Letter And Ministerial Order Op Cadence

Organization: National Defence

0 page(s)
February 2020

Req # A-2019-00699

Mapping of Program and Administrative Services Occupational Group regarding occupational group reform and Pay Equity compliance analysis with the Canadian Human Rights Act

Organization: Treasury Board of Canada Secretariat

0 page(s)
February 2020

Req # A-2018-000950

Any one document that provides the batch number(s) of all REVLIMID used in the comparative studies included in the APO-LENALIDOMIDE abbreviated new drug submission number 218298.

Organization: Health Canada

0 page(s)
January 2020

Req # A-2019-000752

Health Canada Compliance report delivered to CannTrust.

Organization: Health Canada

0 page(s)
January 2020

Req # A-2019-000521

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 19-106665-371.

Organization: Health Canada

0 page(s)
January 2020

Req # A-2019-001374

Any New Drug Submission (NDS), regarding new drugs containing ferric carboxymaltose, also named iron carboxymaltose or iron dextri-maltose: - The related exchanges between Health Canada and the sponsor and the minutes and presentation materials of any meeting between Health Canada and the sponsor.

Organization: Health Canada

0 page(s)
January 2020
Date modified: